Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (25)
  • Open Access

    ARTICLE

    Advancing Breast Cancer Diagnosis: The Development and Validation of the HERA-Net Model for Thermographic Analysis

    S. Ramacharan1,*, Martin Margala1, Amjan Shaik2, Prasun Chakrabarti3, Tulika Chakrabarti4

    CMC-Computers, Materials & Continua, Vol.81, No.3, pp. 3731-3760, 2024, DOI:10.32604/cmc.2024.058488 - 19 December 2024

    Abstract Breast cancer remains a significant global health concern, with early detection being crucial for effective treatment and improved survival rates. This study introduces HERA-Net (Hybrid Extraction and Recognition Architecture), an advanced hybrid model designed to enhance the diagnostic accuracy of breast cancer detection by leveraging both thermographic and ultrasound imaging modalities. The HERA-Net model integrates powerful deep learning architectures, including VGG19, U-Net, GRU (Gated Recurrent Units), and ResNet-50, to capture multi-dimensional features that support robust image segmentation, feature extraction, and temporal analysis. For thermographic imaging, a comprehensive dataset of 3534 infrared (IR) images from the… More >

  • Open Access

    ARTICLE

    A Genetic Algorithm-Based Optimized Transfer Learning Approach for Breast Cancer Diagnosis

    Hussain AlSalman1, Taha Alfakih2, Mabrook Al-Rakhami2, Mohammad Mehedi Hassan2,*, Amerah Alabrah2

    CMES-Computer Modeling in Engineering & Sciences, Vol.141, No.3, pp. 2575-2608, 2024, DOI:10.32604/cmes.2024.055011 - 31 October 2024

    Abstract Breast cancer diagnosis through mammography is a pivotal application within medical image-based diagnostics, integral for early detection and effective treatment. While deep learning has significantly advanced the analysis of mammographic images, challenges such as low contrast, image noise, and the high dimensionality of features often degrade model performance. Addressing these challenges, our study introduces a novel method integrating Genetic Algorithms (GA) with pre-trained Convolutional Neural Network (CNN) models to enhance feature selection and classification accuracy. Our approach involves a systematic process: first, we employ widely-used CNN architectures (VGG16, VGG19, MobileNet, and DenseNet) to extract a… More >

  • Open Access

    REVIEW

    Novel insights on oral squamous cell carcinoma management using long non-coding RNAs

    SUBHAYAN SUR1,*, DIMPLE DAVRAY2, SOUMYA BASU1, SUPRIYA KHEUR3, JAYANTA KUMAR PAL1, SHUCHI NAGAR2, AVINASH SANAP3, BHIMAPPA M. RUDAGI3, SAMIR GUPTA4

    Oncology Research, Vol.32, No.10, pp. 1589-1612, 2024, DOI:10.32604/or.2024.052120 - 18 September 2024

    Abstract Oral squamous cell carcinoma (OSCC) is one of the most prevalent forms of head and neck squamous cell carcinomas (HNSCC) with a poor overall survival rate (about 50%), particularly in cases of metastasis. RNA-based cancer biomarkers are a relatively advanced concept, and non-coding RNAs currently have shown promising roles in the detection and treatment of various malignancies. This review underlines the function of long non-coding RNAs (lncRNAs) in the OSCC and its subsequent clinical implications. LncRNAs, a class of non-coding RNAs, are larger than 200 nucleotides and resemble mRNA in numerous ways. However, unlike mRNA,… More >

  • Open Access

    ARTICLE

    Enhancing Skin Cancer Diagnosis with Deep Learning: A Hybrid CNN-RNN Approach

    Syeda Shamaila Zareen1,*, Guangmin Sun1,*, Mahwish Kundi2, Syed Furqan Qadri3, Salman Qadri4

    CMC-Computers, Materials & Continua, Vol.79, No.1, pp. 1497-1519, 2024, DOI:10.32604/cmc.2024.047418 - 25 April 2024

    Abstract Skin cancer diagnosis is difficult due to lesion presentation variability. Conventional methods struggle to manually extract features and capture lesions spatial and temporal variations. This study introduces a deep learning-based Convolutional and Recurrent Neural Network (CNN-RNN) model with a ResNet-50 architecture which used as the feature extractor to enhance skin cancer classification. Leveraging synergistic spatial feature extraction and temporal sequence learning, the model demonstrates robust performance on a dataset of 9000 skin lesion photos from nine cancer types. Using pre-trained ResNet-50 for spatial data extraction and Long Short-Term Memory (LSTM) for temporal dependencies, the model More >

  • Open Access

    REVIEW

    Circular RNAs in breast cancer diagnosis, treatment and prognosis

    XIAOJIA HUANG1,#, CAILU SONG2,#, JINHUI ZHANG2, LEWEI ZHU3,*, HAILIN TANG2,*

    Oncology Research, Vol.32, No.2, pp. 241-249, 2024, DOI:10.32604/or.2023.046582 - 28 December 2023

    Abstract Breast cancer has surpassed lung cancer to become the most common malignancy worldwide. The incidence rate and mortality rate of breast cancer continue to rise, which leads to a great burden on public health. Circular RNAs (circRNAs), a new class of noncoding RNAs (ncRNAs), have been recognized as important oncogenes or suppressors in regulating cancer initiation and progression. In breast cancer, circRNAs have significant roles in tumorigenesis, recurrence and multidrug resistance that are mediated by various mechanisms. Therefore, circRNAs may serve as promising targets of therapeutic strategies for breast cancer management. This study reviews the More >

  • Open Access

    ARTICLE

    Does a prior cancer diagnosis impact PSA testing? Results from the National Health Interview Survey

    Alon Lazarovich1, Thenappan Chandrasekar2, Alina Basnet3, Gennady Bratslavsky4, Hanan Goldberg4

    Canadian Journal of Urology, Vol.30, No.3, pp. 11551-11557, 2023

    Abstract Introduction: Prostate-specific antigen (PSA) testing remains a controversial issue. However, most urological guidelines recommend PSA testing in men aged 55-69 through a shared decision-making process with the patient. The impact of prior cancer diagnosis on PSA testing is not well-known. To compare PSA testing in men aged 55-69 years with and without a history of cancer (excluding prostate cancer patients).
    Materials and methods: Utilizing the National Health Interview Survey (NHIS), a retrospective cross-sectional study during the year 2018 was carried out. Multivariable logistic regression analysis was implemented to demonstrate potential associations with PSA testing and assess the… More >

  • Open Access

    ARTICLE

    Enhancing Breast Cancer Diagnosis with Channel-Wise Attention Mechanisms in Deep Learning

    Muhammad Mumtaz Ali, Faiqa Maqsood, Shiqi Liu, Weiyan Hou, Liying Zhang, Zhenfei Wang*

    CMC-Computers, Materials & Continua, Vol.77, No.3, pp. 2699-2714, 2023, DOI:10.32604/cmc.2023.045310 - 26 December 2023

    Abstract Breast cancer, particularly Invasive Ductal Carcinoma (IDC), is a primary global health concern predominantly affecting women. Early and precise diagnosis is crucial for effective treatment planning. Several AI-based techniques for IDC-level classification have been proposed in recent years. Processing speed, memory size, and accuracy can still be improved for better performance. Our study presents ECAM, an Enhanced Channel-Wise Attention Mechanism, using deep learning to analyze histopathological images of Breast Invasive Ductal Carcinoma (BIDC). The main objectives of our study are to enhance computational efficiency using a Separable CNN architecture, improve data representation through hierarchical feature… More >

  • Open Access

    ARTICLE

    Smart MobiNet: A Deep Learning Approach for Accurate Skin Cancer Diagnosis

    Muhammad Suleman1, Faizan Ullah1, Ghadah Aldehim2,*, Dilawar Shah1, Mohammad Abrar1,3, Asma Irshad4, Sarra Ayouni2

    CMC-Computers, Materials & Continua, Vol.77, No.3, pp. 3533-3549, 2023, DOI:10.32604/cmc.2023.042365 - 26 December 2023

    Abstract The early detection of skin cancer, particularly melanoma, presents a substantial risk to human health. This study aims to examine the necessity of implementing efficient early detection systems through the utilization of deep learning techniques. Nevertheless, the existing methods exhibit certain constraints in terms of accessibility, diagnostic precision, data availability, and scalability. To address these obstacles, we put out a lightweight model known as Smart MobiNet, which is derived from MobileNet and incorporates additional distinctive attributes. The model utilizes a multi-scale feature extraction methodology by using various convolutional layers. The ISIC 2019 dataset, sourced from… More >

  • Open Access

    ARTICLE

    SNSVM: SqueezeNet-Guided SVM for Breast Cancer Diagnosis

    Jiaji Wang1, Muhammad Attique Khan2, Shuihua Wang1,3, Yudong Zhang1,3,*

    CMC-Computers, Materials & Continua, Vol.76, No.2, pp. 2201-2216, 2023, DOI:10.32604/cmc.2023.041191 - 30 August 2023

    Abstract Breast cancer is a major public health concern that affects women worldwide. It is a leading cause of cancer-related deaths among women, and early detection is crucial for successful treatment. Unfortunately, breast cancer can often go undetected until it has reached advanced stages, making it more difficult to treat. Therefore, there is a pressing need for accurate and efficient diagnostic tools to detect breast cancer at an early stage. The proposed approach utilizes SqueezeNet with fire modules and complex bypass to extract informative features from mammography images. The extracted features are then utilized to train… More >

  • Open Access

    REVIEW

    Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring

    EFFAT ALEMZADEH1, LEILA ALLAHQOLI2, HAMIDEH DEHGHAN3, AFROOZ MAZIDIMORADI4, ALIREZA GHASEMPOUR3, HAMID SALEHINIYA5,*

    Oncology Research, Vol.31, No.5, pp. 667-675, 2023, DOI:10.32604/or.2023.028406 - 21 July 2023

    Abstract Liquid biopsy, including both circulating tumor cells and circulating tumor DNA, is becoming more popular as a diagnostic tool in the clinical management of breast cancer. Elevated concentrations of these biomarkers during cancer treatment may be used as markers for cancer progression as well as to understand the mechanisms underlying metastasis and treatment resistance. Thus, these circulating markers serve as tools for cancer assessing and monitoring through a simple, non-invasive blood draw. However, despite several study results currently noting a potential clinical impact of ctDNA mutation tracking, the method is not used clinically in cancer More > Graphic Abstract

    Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring

Displaying 1-10 on page 1 of 25. Per Page